JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 9 analysts with an average price target of $203.62. This is a potential upside of $202.91 (28578.87%) from yesterday's end of day stock price of $0.71.

Jasper Therapeutics's activity chart (see below) currently has 38 price targets and 72 ratings on display. The stock rating distribution of JSPR is 72.22% BUY and 27.78% HOLD.

Stock Analyst Price Targets - Review

Highest price target for JSPR is $65, Lowest price target is $4, average price target is $20.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 22-Sep-2025. First documented stock forecast 12-Oct-2021.

Currently out of the existing stock ratings of JSPR, 13 are a BUY (72.22%), 5 are a HOLD (27.78%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Sep-2024

$6

$4.95 (471.43%)

6 months 17 days ago
(22-Sep-2025)

0/5 (0%)

$3.46 (136.22%)

Buy Since 08-Jul-2024

$7

6 months 17 days ago
(22-Sep-2025)

0/4 (0%)

$4.5 (180.00%)

Hold Since 08-Jul-2025

$5

$3.95 (376.19%)

$46

9 months ago
(08-Jul-2025)

0/6 (0%)

$1.98 (65.56%)

Hold Since 08-Jul-2025

$4

$2.95 (280.95%)

$15

9 months ago
(08-Jul-2025)

0/2 (0%)

$0.98 (32.45%)

Buy Since 06-May-2024

$40

9 months 1 days ago
(07-Jul-2025)

0/9 (0%)

$34.59 (639.37%)

Show more analysts

Please expand the browser size to see the chart

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 4 price targets and 0 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Matthew Luchini with highest potential upside - $1898.95

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Judah Frommer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?